A very interesting article from Tom Lazenby from Mayet looking how clinical development outsourcing needs to evolve to meet the challenges of the pharma industry...assisted in a small way 😉 by the 4C Life Sciences, Head of R&D Outsourcing Advisory, Rob Aitchison. 4C Life Sciences have developed the Cellular Services Model of outsourcing to address these challenges which client companies say is the first truly innovative approach they have heard for a very long time. If you are interested in hearing more reach out to Rob or Will Sillar to arrange a discussion. #CellularServicesModel #R&D #ClinicalOutsourcing #4CLS #Mayet
Founder - Mayet | Championing enhanced vendor management in clinical trials | Risk Management | Quality Assurance | 3rd Party Oversight | Clinical Trials |
💫 New Blog Post Learn about the evolution of clinical trial outsourcing from cost-cutting to strategic partnerships, and discover how the Cellular Services Model (CSM) addresses key industry challenges, enhances efficiency, and drives innovation in my latest blog. (Link in comments) I would like to thank Rob Aitchison for his collaboration and history lessons that enabled me to get the detail required for this post. #clinicaltrials #outsourcing #history #vendormanagement